LinkedInFacebook
back to homepage

Submission of Abstracts                                                SUBMISSION PAGE


The Scientific Programme Committee (SPC) requires electronic submission of all abstracts for the EUROTOX 2017.  Each abstract, submitted to the EUROTOX congress, is reviewed by SPC. The scientific quality of the abstracts presented contributes substantially towards making the EUROTOX Meetings the leading toxicology event in the Europe. As such, there is a standard for abstract acceptance.

ORAL PRESENTATIONS (Symposia, Workshops)

All submitters of the Scientific proposals for the EUROTOX 2017 Programme have been informed about acceptance and/or rejection of their proposals already in 2016. Proposals that were accepted and included into the Scientific programme of the EUROTOX 2017 were further elaborated by the Promoters and/or Session chairs in 2016. Accepted proposals (CECs, Symposia, Workshops) are listed in the Preliminary Programme, which is posted online. Session chairs will invite speakers in the particular sessions to submit their abstracts. 

There is no abstract submission for the CEC courses.

Abstracts need to be submitted into pre-defined sessions. Drop-down list of the accepted sessions is available at the submission page.

The following guidelines apply for oral presentations:

• Abstract is limited to 250 words (this does not include the title, author’s names and institutions),
• Abstract title is limited to 20 words,
• Max 5 keywords are accepted,
• The abstract may not contain tables, figures or chemical structures,
• All presenters are responsible for registering for the EUROTOX 2017 meeting,
• The complexity of the programme planning process prevents any changes in the type of session, time, or location of presentation. All presenters for programmed abstracts agree to accept the assigned time slot,
• A confirmation/receipt page is provided online; please print a copy for your records

Abstracts describing the results of experimental studies must contain the following:

1. A statement of the rationale and scope of the study,
2. A brief description of the experimental procedures,
3. The data that resulted from the study,
4. Principal conclusion(s) based on interpretation of the results. Phrases such as “results/data will be discussed” convey no information as to the outcome of the studies and are unacceptable.

Abstracts describing educational, ethics, legal, or social initiatives must contain the following:

1. A statement of the rationale and scope of the study,
2. Assessment approach,
3. Study’s results or findings summarized explicitly,
4. Implications for stakeholders. Abstracts describing new initiatives or science policy in the regulatory community must clearly describe the impact on practice of toxicology and/or risk assessment.
5. Care should be taken to clearly distinguish between statements based on documented facts vs. opinions.

POSTER PRESENTATIONS 

Regular abstract submission period for the poster presentations will start on March 1, 2017 and will end on May 1, 2017.

Abstracts need to be submitted into pre-defined topics.  

The following guidelines apply for poster presentations:

• Abstract is limited to 250 words (this does not include the title, author’s names and institutions),
• Abstract title is limited to 20 words,
• Max 5 keywords are accepted,
• The abstract may not contain tables, figures or chemical structures,
• Authors are permitted as „presenting author“ on only ONE abstract.
• All presenting authors are responsible for registering for the EUROTOX 2017 Meeting and for paying the registration fees,
• The cost to submit an abstract is 25 EUR in the regular abstract period.
• Presenting authors must pay the registration fee and abstract fee by June 12, 2017,
• Abstracts submitted in the late-breaking abstract period will not be published in the Toxicology letters,
• A confirmation/receipt page is provided online; please print a copy for your records,
• The complexity of the programme planning process prevents any changes in the type of session, time, or location of presentation. All presenters for programmed abstracts agree to accept the assigned time slot,

Abstracts describing the results of experimental studies must contain the following:

1. A statement of the rationale and scope of the study,
2. A brief description of the experimental procedures,
3. The data that resulted from the study,
4. Principal conclusion(s) based on interpretation of the results. Phrases such as “results/data will be discussed” convey no information as to the outcome of the studies and are unacceptable.

Abstracts describing educational, ethics, legal, or social initiatives must contain the following:

1. A statement of the rationale and scope of the study,
2. Assessment approach,
3. Study’s results or findings summarized explicitly,
4. Implications for stakeholders. Abstracts describing new initiatives or science policy in the regulatory community must clearly describe the impact on practice of toxicology and/or risk assessment.
5. Care should be taken to clearly distinguish between statements based on documented facts vs. opinions.

Acceptance or rejection e-mail will be provided by the SPC by June 5, 2017.

Further instructions for preparing the Poster presentation will be available at the web-site, typically 3 months before the event. 

 

EUROTOXSETOX

© 2016–2017 GUARANT International